Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04588 secretin receptor, putative | Get druggable targets OG5_139196 | All targets in OG5_139196 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | glutamate receptor | 0.0791 | 0.7858 | 0.7858 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0717 | 0.6987 | 0.8891 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0663 | 0.6354 | 0.6929 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0974 | 1 | 1 |
Onchocerca volvulus | Poor gastrulation protein homolog | 0.0128 | 0.0094 | 0.5 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0386 | 0.3108 | 0.3335 |
Loa Loa (eye worm) | receptor family ligand binding region containing protein | 0.0203 | 0.0966 | 0.0966 |
Loa Loa (eye worm) | hypothetical protein | 0.0203 | 0.0966 | 0.0966 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0663 | 0.6354 | 0.6319 |
Loa Loa (eye worm) | metabotropic GABA-B receptor subtype 2 | 0.0203 | 0.0966 | 0.0966 |
Brugia malayi | metabotropic GABA-B receptor subtype 2 | 0.0128 | 0.0094 | 0.012 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0663 | 0.6354 | 0.6319 |
Schistosoma mansoni | amine GPCR | 0.018 | 0.0701 | 0.0671 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0791 | 0.7858 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0128 | 0.0094 | 0.0094 |
Brugia malayi | Receptor family ligand binding region containing protein | 0.0203 | 0.0966 | 0.1229 |
Brugia malayi | metabotropic glutamate receptor type 2 | 0.0386 | 0.3108 | 0.3955 |
Loa Loa (eye worm) | hypothetical protein | 0.0974 | 1 | 1 |
Loa Loa (eye worm) | glutamate receptor | 0.0311 | 0.2236 | 0.2236 |
Onchocerca volvulus | Metabotropic glutamate receptor homolog | 0.0128 | 0.0094 | 0.5 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.09 | 0.9129 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.3548 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ] | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.